Radiotherapy and Immunotherapy Combinations in Non-small Cell Lung Cancer: A Promising Future?

被引：8
|
作者：
Hanna, G. G. [1 ]
Illidge, T. [2 ]
机构：
[1] Queens Univ Belfast, Ctr Canc Res & Cell Biol, 95 Lisburn Rd, Belfast BT9 7AE, Antrim, North Ireland
[2] Univ Manchester, Manchester Acad Hlth Sci Ctr, Inst Canc Sci, Manchester Canc Res Ctr,Christie Hosp, Manchester, Lancs, England
来源：
CLINICAL ONCOLOGY | 2016年 / 28卷 / 11期
关键词：
Checkpoint inhibition; immunotherapy; NSCLC; radiotherapy; IMMUNE-RELATED RESPONSE; TUMOR MICROENVIRONMENT; IONIZING-RADIATION; SOLID TUMORS; MELANOMA; MODULATION; MECHANISMS; IPILIMUMAB; RESISTANCE; DOCETAXEL;
D O I：
10.1016/j.clon.2016.07.014
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The goal of re-programming the host immune system to target malignancy with durable anti-tumour clinical responses has been speculated for decades. In the last decade such speculation has been transformed into reality with unprecedented and durable responses to immune checkpoint inhibitors seen in solid tumours. This mini-review considers the mechanism of action of immune modulating agents and the potential for combination with radiotherapy in the treatment of non-small cell lung cancer. (C) 2016 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码：726 / 731
页数：6
相关论文
共 50 条
  • [21] Duration of Immunotherapy in Non-Small Cell Lung Cancer Survivors: A Lifelong Commitment?
    Putzu, Carlo
    Canova, Stefania
    Paliogiannis, Panagiotis
    Lobrano, Renato
    Sala, Luca
    Cortinovis, Diego Luigi
    Colonese, Francesca
    CANCERS, 2023, 15 (03)
  • [22] Emerging Role of Immunotherapy in Locally Advanced Non-Small Cell Lung Cancer
    Mulherkar, Ria
    Grewal, Amardeep S.
    Berman, Abigail T.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (04) : 212 - 217
  • [23] Is the Combination of Immunotherapy and Radiotherapy in Non-small Cell Lung Cancer a Feasible and Effective Approach?
    Spaas, Mathieu
    Lievens, Yolande
    FRONTIERS IN MEDICINE, 2019, 6
  • [24] Biomarkers of immunotherapy for non-small cell lung cancer
    Shirasawa, Masayuki
    Yoshida, Tatsuya
    Ohe, Yuichiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 54 (01) : 13 - 22
  • [25] Principles of Immunotherapy in Non-Small Cell Lung Cancer
    Hsu, Melinda L.
    Naidoo, Jarushka
    THORACIC SURGERY CLINICS, 2020, 30 (02) : 187 - +
  • [26] Immunotherapy of metastatic non-small cell lung cancer
    Sackmann, Sandra
    Ogundele, Samuel
    Ukena, Dieter
    PNEUMOLOGE, 2019, 16 (06): : 353 - 365
  • [27] Immunotherapy in the treatment of non-small cell lung cancer
    Sundar, Raghav
    Soong, Richie
    Cho, Byoung-Chul
    Brahmer, Julie R.
    Soo, Ross A.
    LUNG CANCER, 2014, 85 (02) : 101 - 109
  • [28] Combination Immunotherapy in Non-small Cell Lung Cancer
    Marmarelis, Melina E.
    Aggarwal, Charu
    CURRENT ONCOLOGY REPORTS, 2018, 20 (07)
  • [29] Adjuvant immunotherapy for non-small cell lung cancer
    Tucker, Zachary C. G.
    Laguna, Benjamin A.
    Moon, Edmund
    Singhal, Sunil
    CANCER TREATMENT REVIEWS, 2012, 38 (06) : 650 - 661
  • [30] Novel immunotherapy in the treatment of advanced non-small cell lung cancer
    Santabarbara, G.
    Maione, P.
    Rossi, A.
    Palazzolo, G.
    Gridelli, C.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (12) : 1571 - 1581
12345